This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Mark Your Calendar for BPI Europe 2023!
9-12 May 2023RAI in Amsterdam

Yanling Wang
Director of Protein Expression & CLD at Hengenix Biotech, Inc.


I have been working at Hengenix Biotech Inc, a therapeutical Ab developing company, for 11 years focusing on stable cell line development for manufacture and protein expression for early stage lead discovery and function validation. We have established the expression system from random integration to site specific integration, from UCOE to GS, then GS-transposon system. The project involved monoclonal antibody, VHH nanobody, bi-specific, and asymmetrical Abs. Also include the biosimilar and innovated molecules.

Agenda Sessions

  • Hard-to-express and problematic multi-specific Ab, CLD, development and process